# FDA Inspection 1107967 - Finorga - September 20, 2019

Source: https://www.keypedia.com/records/fda_inspections/finorga/a940b8eb-05f8-4cb7-88b0-787f5b78d63b
Source feed: FDA_Inspections

> FDA Inspection 1107967 for Finorga on September 20, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1107967
- Company Name: Finorga
- Inspection Date: 2019-09-20
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1287752 - 2023-11-24](https://www.keypedia.com/records/fda_inspections/finorga/14fe5310-41ac-472e-bf33-68fe760ca362)
- [FDA Inspection 988946 - 2016-09-23](https://www.keypedia.com/records/fda_inspections/finorga/ed3a6a63-fec2-4540-91b1-611b83780a21)
- [FDA Inspection 862778 - 2013-12-13](https://www.keypedia.com/records/fda_inspections/finorga/710f7046-2bc3-43cb-a14f-d2259c7bf94f)

Company: https://www.keypedia.com/companies/finorga/e1292a8b-3cb4-4565-a290-ff6c36db22a5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c